These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5164739)

  • 1. [Elimination of triamterene, an antikaliuretic, and its phenolic metabolite, 2,4,7-triamino-6-p-hydroxyphenylpteridine, in the urine of subjects with normal liver function and in subjects suffering from liver cirrhosis].
    Andrasch H; Fink T; Schmid E
    Z Gastroenterol; 1971; 9(4):240-5. PubMed ID: 5164739
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered hydroxylation rate of triamterene in patients with liver cirrhosis.
    Gundert-Remy U; Müller-Herrmann R; Mutschler E; Schäfer M; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):353-7. PubMed ID: 7118322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triamterene kinetics and dynamics in cirrhosis.
    Villeneuve JP; Rocheleau F; Raymond G
    Clin Pharmacol Ther; 1984 Jun; 35(6):831-7. PubMed ID: 6734036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of xipamide and triamterene in healthy probands].
    Diembeck W; Dies R; Heinz N
    Arzneimittelforschung; 1982; 32(11):1482-5. PubMed ID: 6891256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene.
    Muirhead MR; Somogyi AA; Rolan PE; Bochner F
    Clin Pharmacol Ther; 1986 Oct; 40(4):400-7. PubMed ID: 3757403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipyrone metabolism in liver disease.
    Zylber-Katz E; Caraco Y; Granit L; Levy M
    Clin Pharmacol Ther; 1995 Aug; 58(2):198-209. PubMed ID: 7648770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed elimination of triamterene and its active metabolite in chronic renal failure.
    Knauf H; Möhrke W; Mutschler E
    Eur J Clin Pharmacol; 1983; 24(4):453-6. PubMed ID: 6861860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of the metabolism of 7-chlor-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-on].
    Steidinger J; Schmid E
    Arzneimittelforschung; 1970 Sep; 20(9):1232-5. PubMed ID: 5536799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Age dependence of the pharmacokinetics of triamterene].
    Stopp M; Bräunlich H
    Acta Biol Med Ger; 1973; 30(1):121-32. PubMed ID: 4707945
    [No Abstract]   [Full Text] [Related]  

  • 11. Variations in the fate of triameterene.
    Pruitt AW; Winkel JS; Dayton PG
    Clin Pharmacol Ther; 1977 May; 21(5):610-9. PubMed ID: 870273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis.
    Sörgel F; Ettinger B; Benet LZ
    J Pharm Sci; 1986 Feb; 75(2):129-32. PubMed ID: 3958920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of triameterene with cortisol determination in urine.
    Radó JP; Végh L; Sawinsky I
    Horm Metab Res; 1974 Sep; 6(5):429-30. PubMed ID: 4423766
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of electrocardiographic modifications in the course of treatment with 2-4-7-triamino-6-phenyl-pteridine (triamterene)].
    Rubegni M; Ravenni G; Forconi S
    Minerva Cardioangiol; 1965 Oct; 13(10):682-9. PubMed ID: 5854399
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and urinary levels of triamterene and certain metabolites after oral administration to man.
    Gundert-Remy U; von Kenne D; Weber E; Geissler HE; Grebian B; Mutschler E
    Eur J Clin Pharmacol; 1979 Aug; 16(1):39-44. PubMed ID: 499298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal metabolism of morphine in cirrhosis.
    Patwardhan RV; Johnson RF; Hoyumpa A; Sheehan JJ; Desmond PV; Wilkinson GR; Branch RA; Schenker S
    Gastroenterology; 1981 Dec; 81(6):1006-11. PubMed ID: 7286578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug induced nephrolithiasis: observation of an oxalate and hydroxylated triamterene stone (author's transl)].
    Baudin S; Rodrigue H
    Nephrologie; 1980; 1(4):183-5. PubMed ID: 7301028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The identification and quantitation of triamterene in blood and urine from a fatal aircraft accident victim.
    White V; Canfield DV; Hordinsky J
    J Anal Toxicol; 1994; 18(1):52-3. PubMed ID: 8127086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.